TP53 and Miyoshi myopathy: Several driver genes, such as KRAS/NRAS, TP53, BRAF, and CCND1, frequently harbor mutations in MM.20 The mutation status of these genes is increasingly examined in clinical research for its potential in guiding personalized treatment.20-22 Nevertheless, the prognostic significance of these mutations is limited, as only a few are notably associated with prognosis.